Skip to main content
Clinical Trials/NCT04463316
NCT04463316
Recruiting
N/A

GROWing Up With Rare GENEtic Syndromes ….When Children With Complex Genetic Syndromes Reach Adult Age

dr. Laura C. G. de Graaff-Herder1 site in 1 country600 target enrollmentOctober 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prader-Willi Syndrome
Sponsor
dr. Laura C. G. de Graaff-Herder
Enrollment
600
Locations
1
Primary Endpoint
Medication use
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Introduction Rare complex syndromes Patients with complex genetic syndromes, by definition, have combined medical problems affecting multiple organ systems, and intellectual disability is often part of the syndrome. During childhood, patients with rare genetic syndromes receive multidisciplinary and specialized medical care; they usually receive medical care from 3-4 medical specialists.

Increased life expectancy Although many genetic syndromes used to cause premature death, improvement of medical care has improved life expectancy. More and more patients are now reaching adult age, and the complexity of the syndrome persists into adulthood. However, until recently, multidisciplinary care was not available for adults with rare genetic syndromes. Ideally, active and well-coordinated health management is provided to prevent, detect, and treat comorbidities that are part of the syndrome. However, after transition from pediatric to adult medical care, patients and their parents often report fragmented poor quality care instead of adequate and integrated health management. Therefore, pediatricians express the urgent need for adequate, multidisciplinary adult follow up of their pediatric patients with rare genetic syndromes.

Medical guidelines for adults not exist and the literature on health problems in these adults is scarce. Although there is a clear explanation for the absence of adult guidelines (i.e. the fact that in the past patients with rare genetic syndromes often died before reaching adult age), there is an urgent need for an overview of medical issues at adult age, for 'best practice' and, if possible, for medical guidelines.

The aim of this study is to get an overview of medical needs of adults with rare genetic syndromes, including:

  1. comorbidities
  2. medical and their impact on quality of life
  3. medication use
  4. the need for adaption of medication dose according to each syndrome

Methods and Results This is a retrospective file study. Analysis will be performed using SPSS version 23 and R version 3.6.0.

Registry
clinicaltrials.gov
Start Date
October 1, 2018
End Date
January 1, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
dr. Laura C. G. de Graaff-Herder
Responsible Party
Sponsor Investigator
Principal Investigator

dr. Laura C. G. de Graaff-Herder

Principal investigator

Erasmus Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients with rare syndromes or rare congenital diseases visiting the multidisciplinary outpatient clinic for patients with rare diseases at the department of endocrinology, internal medicine, Erasmus Medical Center.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Medication use

Time Frame: 1 year

Use of all medication

Presence of physical health problems

Time Frame: 1 year

For example: presence of hypertension, diabetes mellitus, hypercholesterolemia, scoliosis, sleep apnea, hypothyroidism, obesity, psychosis etc.

Laboratory values

Time Frame: 1 year

For example: glucose, hemoglobin, hematocrit, thyroid hormone, TSH, estrogen, testosterone, LH, FSH, LDL-cholesterol, triglycerides, ASAT, ALAT, gamma-GT, etc

Physical and psychological complaints

Time Frame: 1 year

For example: daytime sleepiness, obstipation, back pain, headache, behavioral problems, fatigue, nycturia, blurry vision, depressive symptoms, etc.

Study Sites (1)

Loading locations...

Similar Trials